Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.
Sun, J-M; Ahn, Y C; Choi, E K; Ahn, M-J; Ahn, J S; Lee, S-H; Lee, D H; Pyo, H; Song, S Y; Jung, S-H; Jo, J S; Jo, J; Sohn, H J; Suh, C; Lee, J S; Kim, S-W; Park, K.
; 24(8): 2088-92, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23592701
Surgery for limited-stage small-cell lung cancer.
Opening a Chromatin Gate to Metastasis.
Chemotherapy for brain metastases from small cell lung cancer.
Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.
Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.
Origins, genetic landscape, and emerging therapies of small cell lung cancer.
The role of prophylactic cranial irradiation for patients with small-cell lung cancer.
Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.
Small-Cell Neuroendocrine Tumors: Cell State Trumps the Oncogenic Driver.
Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer.